Effect	O
of	O
testosterone	B:C0039601
on	O
the	O
Connexin37	B:C3883963
of	O
sexual	O
mature	O
mouse	B:C0025929
cumulus	B:C0227885
oocyte	B:C0029045
complex	O
.	O

Recent	O
researches	O
demonstrate	O
that	O
pre-treatment	B:C0087111
with	O
androgen	B:C0002844
could	O
increase	O
retrieved	O
oocytes	B:C0029045
number	O
and	O
clinical	O
pregnancy	O
rate	O
in	O
poor	O
ovarian	O
response	O
(	O
POR	O
)	O
patients	O
.	O

In	O
view	O
of	O
gap	B:C1154413
junction	I:C1154413
intercellular	I:C1154413
communication	I:C1154413
(	O
gap	B:C1154413
junction	I:C1154413
intercellular	I:C1154413
communication	I:C1154413
)	O
is	O
important	O
for	O
follicular	B:C0018120
growth	B:C0018270
,	O
and	O
androgen	B:C0002844
plays	O
an	O
important	O
role	O
in	O
improving	O
prognosis	B:C0033325
of	O
POR	O
patients	O
,	O
we	O
speculate	O
that	O
androgen	B:C0002844
can	O
increase	O
the	O
expression	B:C1171362
of	O
connexin	B:C0110611
in	O
follicle	B:C0018120
cells	B:C0007634
,	O
and	O
improve	B:C0184511
ovarian	B:C0205065
microenvironment	B:C0014406
,	O
thus	O
can	O
promote	O
ovarian	O
response	O
.	O

The	O
objective	O
of	O
the	O
research	O
is	O
to	O
study	O
the	O
effect	O
of	O
testosterone	B:C0039601
on	O
connexin37	B:C0214283
(	O
connexin37	B:C0214283
)	O
expression	B:C1171362
so	O
as	O
to	O
provide	O
theoretical	O
basis	O
for	O
adding	O
testosterone	B:C0039601
in	O
treatment	B:C0087111
of	O
POR	O
.	O

Cumulus	B:C0227885
-	O
oocyte	B:C0029045
-cells	I:C0029045
(	O
Cumulus	B:C0029045
-	I:C0029045
oocyte	I:C0029045
-	I:C0029045
cells	I:C0029045
)	O
were	O
collected	O
from	O
ICR	B:C0025925
mice	I:C0025925
ovaries	B:C0029939
,	O
and	O
were	O
cultured	B:C0007585
in	O
vitro	O
for	O
48	O
h	O
and	O
then	O
treated	B:C0332293
with	I:C0332293
testosterone	B:C0039601
(	O
testosterone	B:C0039601
)	O
at	O
various	O
concentration	O
.	O

To	O
assess	O
whether	O
the	O
effect	O
of	O
androgen	B:C0002844
on	O
connexin37	B:C3883963
expression	B:C1171362
is	O
mediated	O
through	O
androgen	B:C1155499
receptor	I:C1155499
(	I:C1155499
AR	I:C1155499
)	I:C1155499
pathway	I:C1155499
,	O
Cumulus	B:C0029045
-	I:C0029045
oocyte	I:C0029045
-	I:C0029045
cells	I:C0029045
were	O
cultured	B:C0007585
in	O
vitro	O
with	O
Flutamide	B:C0016384
(	O
androgen	B:C0016384
receptor	I:C0016384
antagonist	I:C0016384
)	O
.	O

The	O
expression	B:C1171362
of	O
connexin37	B:C3883963
was	O
determined	O
by	O
western	B:C0949466
blot	I:C0949466
.	O

The	O
expression	B:C1171362
of	O
connexin37	B:C3883963
in	O
Cumulus	B:C0029045
-	I:C0029045
oocyte	I:C0029045
-	I:C0029045
cells	I:C0029045
which	O
were	O
treated	B:C0332293
with	I:C0332293
testosterone	B:C0039601
was	O
higher	O
than	O
that	O
of	O
control	O
group	O
.	O

connexin37	B:C3883963
increased	O
with	O
the	O
elevated	O
testosterone	B:C0039601
concentrations	O
.	O

connexin37	B:C3883963
was	O
lower	O
in	O
androgen	B:C0016384
receptor	I:C0016384
antagonist	I:C0016384
group	O
(	O
2.57	O
±	O
0.12	O
)	O
than	O
the	O
corresponding	O
testosterone	B:C0039601
concentrations	O
group	O
(	O
4.42	O
±	O
0.28	O
)	O
.	O

There	O
was	O
close	O
relationship	O
between	O
gap	B:C0110611
junction	I:C0110611
protein	I:C0110611
and	O
ovarian	O
response	O
,	O
which	O
suggested	O
that	O
androgen	B:C0002844
could	O
promote	O
ovarian	O
response	O
by	O
increasing	O
the	O
expression	B:C1171362
of	O
connexin37	B:C3883963
in	O
follicle	B:C0018120
.	O

Androgen	B:C0002844
plays	O
an	O
important	O
role	O
in	O
ovarian	O
response	O
through	O
the	O
AR	B:C1155499
pathway	I:C1155499
and	O
non-AR	B:C0037080
pathway	I:C0037080
.	O

